Kranz Sarah, Pimpin Laura, Fawzi Wafaie, Duggan Christopher, Webb Patrick, Mozaffarian Dariush
1 Tufts Friedman School of Nutrition Science and Policy, Boston, MA, USA.
2 Harvard School of Public Health, Boston, MA, USA.
Food Nutr Bull. 2017 Jun;38(2):260-266. doi: 10.1177/0379572117696663. Epub 2017 Mar 10.
Although vitamin A supplementation reduces child mortality, it remains unclear whether dosing frequency, total dose, or duration modifies effectiveness.
Determine whether mortality effects of vitamin A vary by dosing frequency, total dose, or duration.
Meta-analysis of randomized controlled trials, identified by systematic review and expert opinion, utilizing relatively standard World Health Organization doses in children <5 years. Meta-regression evaluated whether mortality effects varied by dosing frequency, total dose, or supplementation duration.
Identified 17 trials, including 1,180,718 children, mean (standard deviation [SD]) age 31.5 (15.4) months at baseline. Supplementation frequency ranged every 3 months-every 2 years, supplementation duration 4-60 months (mean = 15.4; SD = 12.8), and total dose 134,361-2,200,000 IU (mean = 667,132 IU; SD = 540,795). Compared with control, vitamin A reduced mortality 22% (95% confidence interval [CI] = 10-32; P = 0.002). This protective effect was not modified by increasing supplementation frequency (dose/year: relative risk [RR] = 1.02; 95% CI = 0.98-1.06; P = .22), total dose (per 200,000 IU: RR = 1.02; 95% CI = 0.97-1.06; P = .31), nor supplementation duration (per year: RR = 1.06; 95% CI = 0.97-1.15; P = 0.14). Multivariate meta-regression showed similar results. Sensitivity analyses excluding 1 controversial trial (Aswathi 2013) did not alter findings.
Results confirm benefits of vitamin A supplementation in children <5 years in nations with vitamin A deficiency, without influence of frequency, total dose, or dosing duration within ranges evaluated. These findings inform design and efficiency of vitamin A supplementation policies.
尽管补充维生素A可降低儿童死亡率,但给药频率、总剂量或持续时间是否会影响其效果仍不清楚。
确定维生素A对死亡率的影响是否因给药频率、总剂量或持续时间而异。
通过系统评价和专家意见确定随机对照试验进行荟萃分析,对5岁以下儿童采用相对标准的世界卫生组织剂量。荟萃回归评估死亡率影响是否因给药频率、总剂量或补充持续时间而异。
共纳入17项试验,包括1,180,718名儿童,基线时平均(标准差[SD])年龄为31.5(15.4)个月。补充频率为每3个月至每2年一次,补充持续时间为4至60个月(平均=15.4;SD=12.8),总剂量为134,361至2,200,000国际单位(平均=667,132国际单位;SD=540,795)。与对照组相比,维生素A使死亡率降低了22%(95%置信区间[CI]=10-32;P=0.002)。增加补充频率(每年剂量:相对风险[RR]=1.02;95%CI=0.98-1.06;P=0.22)、总剂量(每200,000国际单位:RR=1.02;95%CI=0.97-1.06;P=0.31)或补充持续时间(每年:RR=1.06;95%CI=0.97-1.15;P=0.14)均未改变这种保护作用。多变量荟萃回归显示了类似结果。排除1项有争议的试验(Aswathi 2013)后的敏感性分析未改变研究结果。
结果证实了在维生素A缺乏国家,补充维生素A对5岁以下儿童有益,在所评估的频率、总剂量或给药持续时间范围内无影响。这些发现为维生素A补充政策的设计和效率提供了参考。